Cartesian Therapeutics, Inc.
RNAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $213 | $77 | $106 | $114 |
| Short-Term Investments | $0 | $0 | $28 | $14 |
| Receivables | $1 | $9 | $10 | $10 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $5 | $4 | $0 |
| Total Curr. Assets | $217 | $91 | $148 | $144 |
| Property Plant & Equip (Net) | $15 | $12 | $14 | $12 |
| Goodwill | $48 | $48 | $0 | $0 |
| Intangibles | $151 | $151 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $1 | $1 | $1 |
| Total NC Assets | $218 | $214 | $18 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $435 | $305 | $166 | $160 |
| Liabilities | – | – | – | – |
| Payables | $0 | $3 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $8 | $6 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $2 | $1 | $54 |
| Other Curr. Liab. | $20 | $56 | $0 | $0 |
| Total Curr. Liab. | $23 | $68 | $25 | $72 |
| LT Debt | $0 | $0 | $18 | $20 |
| Deferred Rev, NC | $0 | $4 | $0 | $11 |
| Deferred Tax Liab, NC | $16 | $322 | $0 | $0 |
| Other NC Liab. | $392 | $343 | $19 | $25 |
| Total NC Liab. | $419 | $677 | $47 | $65 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $14 | $11 | $12 | $10 |
| Total Liabilities | $442 | $745 | $72 | $137 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$692 | -$615 | -$395 | -$430 |
| AOCI | -$5 | -$5 | -$5 | -$5 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$7 | -$440 | $94 | $23 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $435 | $305 | $166 | $160 |
| Net Debt | -$213 | -$77 | -$80 | -$88 |